Replimune Group (NASDAQ:REPL) reported quarterly earnings results on February 03, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $-0.77, beating the consensus estimate of $-0.83 by $0.06 per share. Revenue came in at , missing the estimate of $3.2M.
Replimune Group's stock moved following the earnings release. The stock currently trades at $7.00 with a market capitalization of $774.6M.